David Coman

David Coman is currently the Chief Executive Officer & Director at BGB Group LLC since 2024.
He also holds the position of SVP-Corporate Communications & Patient Recruitment at Quintiles Transnational Corp.
since 2011.
Previously, he served as the Chief Executive Officer & Director at Lifesci Acquisition II Corp., Science 37 Holdings, Inc., and Science 37, Inc. He was also the Vice President-Global Marketing at Dendrite International, Inc. and the Chief Marketing Officer at IQVIA, Inc. Additionally, he worked as the Chief Strategy Officer at ERT Operating Co. from 2016 to 2019 and as the Chief Marketing Officer at IMS Health, Inc. Mr. Coman completed his undergraduate degree at Michigan State University and holds an MBA from Kellogg School of Management.